Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors

Clinical trial NCT05169944 · COMPLETED

Trial details

NCT number: NCT05169944
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain Cancer Malignant Brain Tumor Recurrent Brain Tumor Progressive Malignant Brain Tumor Brain Tumor, Pediatric Brain Tumor Adult

Start date: 2022-04-22
Primary completion: 2024-09-30
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.